Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). (Q43296433)
Jump to navigation
Jump to search
scientific article published in September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). |
scientific article published in September 2009 |
Statements
1 reference
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). (English)
1 reference
1 reference
Núria Pérez-Alvarez
1 reference
Bonaventura Clotet
1 reference
Glòria Garrabou
1 reference
Carla Estany
1 reference
Benjamí Rodríguez-Santiago
1 reference
Lluís Force
1 reference
Angels Masabeu
1 reference
Pilar Barrufet
1 reference
Josep Cucurull
1 reference
Pere Domingo
1 reference
MULTINEKA Study Group
1 reference
1 September 2009
1 reference
1 reference
Identifiers
1 reference